Creative Planning’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2
Closed -$5K – 2379
2022
Q2
$5K Hold
2
– – ﹤0.01% 2227
2022
Q1
$10K Hold
2
– – ﹤0.01% 2193
2021
Q4
$14K Hold
2
– – ﹤0.01% 2048
2021
Q3
$19K Hold
2
– – ﹤0.01% 2049
2021
Q2
$34K Hold
2
– – ﹤0.01% 1966
2021
Q1
$36K Hold
2
– – ﹤0.01% 2391
2020
Q4
$36K Buy
+2
New +$32.5K ﹤0.01% 2131

Other funds holding MTRI

Creative Planning's MTRI Position: Q3 2022 in Review

Creative Planning sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2022, closing a stake of 2 shares — an estimated $5K sold.

Creative Planning first reported a position in MTRI in Q4 2020 and held it in 7 quarters. The position peaked at $36K in Q1 2021. 7 funds tracked by Wall St. Rank hold MTRI as of Q3 2022.

  • Creative Planning reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Creative Planning sold 2 Mentari Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $5K.
  • Creative Planning first reported a position in Mentari Therapeutics, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Creative Planning's Mentari Therapeutics, Inc. Common Stock position peaked at $36K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.